| Code | 8155E | ||||||||||
| MA number | 59/0303/24-S | ||||||||||
| Product Form: | cps dur 21x2 mg (blis.PVC/PCTFE/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | AS GRINDEKS, Latvia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | blister PVC/PCTFE/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 14.12.2024 |
| Validity: | 14.12.2029 |
| Dokument: |
Pomalidomid_Formulár informovanosti o rizikách.pdf
|
| Dokument: |
Pomalidomid_Karta pacienta.pdf
|
| PIL: |
PIL_Pomalidomid Grindeks_08.2025.pdf
|
| SPC: |
SPC_Pomalidomid Grindeks_09.2025.pdf
|
| Dokument: |
Pomalidomid_Prirucka pre pacientov.pdf
|
| Dokument: |
Pomalidomid_Prirucka pre zdravotnickych pracovnikov.pdf
|
| Safety feature | Yes |
| Data update: | 19.12.2024 |
